4.
SLE与Rhupus综合征患者临床特点及双手腕超声下病变的比较
Comparison of the clinical and ultrasonographic features between SLE patients and Rhupus syndrome patients
| Clinical and ultrasonographic features | SLE group (n=69) | Rhupus syndrome group (n=15) | P |
| RF, rheumatoid factor; GS, grey scale; PD, power Doppler. Other abbreviations as in Table 1. | |||
| Female, n (%) | 62 (88.5) | 14 (93.3) | 0.576 |
| Age/years, x±s | 43.7±15.0 | 48.4±14.9 | 0.651 |
| Disease duration/years, median (min, max) | 6.0 (0.1, 40.0) | 10.0 (1.0, 46.0) | 0.061 |
| Joint involvement, n (%) | 55 (79.7) | 15 (100.0) | 0.064 |
| Lupus nephritis, n (%) | 34 (49.2) | 8 (53.3) | 0.776 |
| Hematologic involvement, n (%) | 29 (42.0) | 12 (80.0) | <0.001 |
| Serositis, n (%) | 3 (4.3) | 7 (46.7) | <0.001 |
| ANA positive, n (%) | 69 (100.0) | 15 (100.0) | |
| Anti-dsDNA positive, n (%) | 46 (66.7) | 12 (80.0) | 0.311 |
| Anti-Sm, n (%) | 12 (17.3) | 6 (40.0) | 0.053 |
| Anti-nRNP, n (%) | 30 (43.4) | 7 (46.6) | 0.822 |
| Anti-rRNP, n (%) | 16 (23.2) | 3 (20.0) | 0.789 |
| Anti-SSA, n (%) | 35 (50.7) | 7 (46.6) | 0.776 |
| SLEDAI, x±s | 10.0±6.2 | 10.0±5.3 | 0.834 |
| Complement 3/(g/L), x±s | 0.64±0.29 | 0.56±0.35 | 0.476 |
| IgG/(g/L), x±s | 18.7±7.7 | 23.0±8.1 | 0.727 |
| RF, n (%) | 15 (21.7) | 10 (66.7) | 0.060 |
| Synovial hyperplasia (GS>0), n (%) | 25 (36.2) | 11 (73.3) | 0.083 |
| Synovitis (PD>0), n (%) | 11 (18.9) | 5 (33.3) | 0.121 |
| GS score, x±s | 1.6±4.1 | 7.4±6.4 | 0.040 |
| PD score, x±s | 0.4±1.4 | 1.1±1.8 | 0.613 |
| Bone erosion, n (%) | 10 (14.5) | 10 (66.7) | <0.001 |